BSRBR-RA Publication News

Wondering where all that data we collect goes?  Have a look at the newest publications using BSRBR-RA data:

Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register

There are also lay summaries available for many of our publications which provide a more accessible overview.  Lay summaries and details of BSRBR-RA publications can be found on our research page.